发明名称 Protocol for risk stratification of ischemic events and optimized individualized treatment
摘要 A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject.
申请公布号 US7754489(B2) 申请公布日期 2010.07.13
申请号 US20080347466 申请日期 2008.12.31
申请人 CORA HEALTHCARE, INC. 发明人 COHEN ELI
分类号 G01N33/86 主分类号 G01N33/86
代理机构 代理人
主权项
地址
您可能感兴趣的专利